The effects of VIP/pituitary adenylate cyclase-activating polypeptide receptor (VPAC) agonist on intestinal epithelium-like Caco-2 monolayers.
- Mayuree Rodrat (14142004)
- Kannikar Wongdee (13531585)
- Jarinthorn Teerapornpuntakit (4571038)
- Jirawan Thongbunchoo (8911367)
- Duangrudee Tanramluk (10662737)
- Ratchaneevan Aeimlapa (13531579)
- Nithipak Thammayon (14142007)
- Natchayaporn Thonapan (14142010)
- Pathnaree Wattano (14142013)
- Narattaphol Charoenphandhu (4571035)
Publication date
November 2022
DOI Publisher
Public Library of Science (PLoS)Abstract
(A) Timeline of Experiment 1. (B) Transepithelial calcium flux and (C–E) epithelial electrical parameters (PD, Isc, and TER) across Caco-2 monolayers that were directly exposed to 0.1 and 1 μM VPAC agonist on the basolateral side for 30 min. *p < 0.05 vs. control group (open bar, one-way ANOVA with Tukey’s multiple comparison test).</p
Add to ORKG